ACTRN12619000508178
已完成
未知
A cluster randomised controlled trial of a MedicineInsight educational quality improvement program to improve the diagnosis and treatment of chronic hepatitis C in Australian general practice - the EQUIP-HEPC trial
PS MedicineWise (Not-for-profit)0 个研究点目标入组 201 人2019年3月28日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- PS MedicineWise (Not-for-profit)
- 入组人数
- 201
- 状态
- 已完成
- 最后更新
- 4年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •General Practice sites:
- •1\.Participates in the MedicineInsight Program and meets MedicineInsight data quality requirements
- •2\.Located in a geographical area serviced by one of the CSS field force delivering the intervention
- •3\.Use of Medical Director or Best Practice for EHR management
- •4\.Has 5 or more patients with possible or confirmed CHC\* who visited the practice at least once in the 2 years prior to randomisation
- •\*As part of a previous project related to hepatitis C, we have developed a set of search algorithms that scan the data in MedicineInsight for terms that indicate confirmed or possible CHC. These algorithms and terms are outlined in detail by Chidwick et al (2018\) . The algorithms search for a patient’s most recent docle and pyefinch codes as well as free text expressions pertaining to hepatitis C in clinical system records that describe reason for encounter, reason for prescription, or diagnosis. Additional criteria are applied to confirm CHC in patients whose most recent status is indeterminate, including prescriptions, tests, and complications related to CHC.
排除标准
- •Practices that participated in the 2017 NPS MedicineWise educational program on Hepatitis C will be excluded.
- •Practices that withdraw their consent to participate in this study, or in the MedicineInsight program, during the period of analysis will not be included in this study. Practice\-level withdrawals are rare in MedicineInsight. Data for patients who opt\-out from the program will be excluded from the study.
结局指标
主要结局
未指定
相似试验
已完成
不适用
Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge): Randomised Controlled TrialSevere and persistent mental illnessSchizophreniaBipolar disorderSevere depressionSchizoaffective disorderMental Health - SchizophreniaMental Health - Psychosis and personality disordersMental Health - DepressionMental Health - Other mental health disordersPublic Health - Health service researchACTRN12620000577910The Pharmacy Guild of Australia351
已完成
不适用
A comparison of dentist-led, teacher-led, peer-led and self-learning strategies for educating school children aged 10-13 years about prevention of oral diseases including tooth decay, gum disease and oral cancerOral health education for preventing dental caries, gingivitis and oral cancerOral HealthPreventing dental caries, gingivitis and oral cancerISRCTN39391017Shaikh Zayed Medical Complex (Pakistan)1,800
已完成
不适用
Clinical trial on the efficacy of two interventions for discontinuing long term benzodiazepine use in primary careISRCTN13024375Health Service of the Balearic Islands (Servei de Salut de les Illes Balears [IB-salut]) (Spain)495
进行中（未招募）
不适用
More Good Days At School (MGDAS): Building relationships to promote health, happiness, and learningMental health and wellbeing in pupils and school staffMental and Behavioural DisordersISRCTN12074782niversity College London15,867
已完成
不适用
Xience® or Vision® stent - Management of Angina in the elderlyCoronary diseaseacute coronary syndromesCirculatory SystemOther acute ischaemic heart diseasesISRCTN92243650Brighton and Sussex University Hospitals NHS Trust (UK)800